178 related articles for article (PubMed ID: 19625187)
21. Bismuth complexes inhibit the SARS coronavirus.
Yang N; Tanner JA; Zheng BJ; Watt RM; He ML; Lu LY; Jiang JQ; Shum KT; Lin YP; Wong KL; Lin MC; Kung HF; Sun H; Huang JD
Angew Chem Int Ed Engl; 2007; 46(34):6464-8. PubMed ID: 17645269
[No Abstract] [Full Text] [Related]
22. Generation of predictive pharmacophore model for SARS-coronavirus main proteinase.
Zhang XW; Yap YL; Altmeyer RM
Eur J Med Chem; 2005 Jan; 40(1):57-62. PubMed ID: 15642409
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of novel test compounds for antiviral chemotherapy of severe acute respiratory syndrome (SARS).
Kesel AJ
Curr Med Chem; 2005; 12(18):2095-162. PubMed ID: 16101496
[TBL] [Abstract][Full Text] [Related]
24. NTPase/helicase of Flaviviridae: inhibitors and inhibition of the enzyme.
Borowski P; Niebuhr A; Schmitz H; Hosmane RS; Bretner M; Siwecka MA; Kulikowski T
Acta Biochim Pol; 2002; 49(3):597-614. PubMed ID: 12422230
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of the helicase activity of HCV NTPase/helicase by 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide-5 '-triphosphate (ribavirin-TP).
Borowski P; Lang M; Niebuhr A; Haag A; Schmitz H; Schulze zur Wiesch J; Choe J; Siwecka MA; Kulikowski T
Acta Biochim Pol; 2001; 48(3):739-44. PubMed ID: 11833782
[TBL] [Abstract][Full Text] [Related]
26. Inhibitors of the NTPase/helicases of hepatitis C and related Flaviviridae viruses.
Bretner M; Najda A; Podwińska R; Baier A; Paruch K; Lipniacki A; Piasek A; Borowski P; Kulikowski T
Acta Pol Pharm; 2004 Dec; 61 Suppl():26-8. PubMed ID: 15909930
[TBL] [Abstract][Full Text] [Related]
27. Three dimensional model of severe acute respiratory syndrome coronavirus helicase ATPase catalytic domain and molecular design of severe acute respiratory syndrome coronavirus helicase inhibitors.
Hoffmann M; Eitner K; von Grotthuss M; Rychlewski L; Banachowicz E; Grabarkiewicz T; Szkoda T; Kolinski A
J Comput Aided Mol Des; 2006 May; 20(5):305-19. PubMed ID: 16972168
[TBL] [Abstract][Full Text] [Related]
28. Effects of the aryl linker and the aromatic substituent on the anti-HCV activities of aryl diketoacid (ADK) analogues.
Kim J; Kim KS; Lee HS; Park KS; Park SY; Kang SY; Lee SJ; Park HS; Kim DE; Chong Y
Bioorg Med Chem Lett; 2008 Aug; 18(16):4661-5. PubMed ID: 18644717
[TBL] [Abstract][Full Text] [Related]
29. Understanding helicases as a means of virus control.
Frick DN; Lam AM
Curr Pharm Des; 2006; 12(11):1315-38. PubMed ID: 16611118
[TBL] [Abstract][Full Text] [Related]
30. Pharmacophore modelling of vanillin derivatives, favipiravir, chloroquine, hydroxychloroquine, monolaurin and tetrodotoxin as M
Law WY; Asaruddin MR; Bhawani SA; Mohamad S
BMC Res Notes; 2020 Nov; 13(1):527. PubMed ID: 33176880
[TBL] [Abstract][Full Text] [Related]
31. Molecular model of SARS coronavirus polymerase: implications for biochemical functions and drug design.
Xu X; Liu Y; Weiss S; Arnold E; Sarafianos SG; Ding J
Nucleic Acids Res; 2003 Dec; 31(24):7117-30. PubMed ID: 14654687
[TBL] [Abstract][Full Text] [Related]
32. In Silico Binding of 2-Aminocyclobutanones to SARS-CoV-2 Nsp13 Helicase and Demonstration of Antiviral Activity.
Mohammad TSH; Gupta Y; Reidl CT; Nicolaescu V; Gula H; Durvasula R; Kempaiah P; Becker DP
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982188
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and activity of an octapeptide inhibitor designed for SARS coronavirus main proteinase.
Gan YR; Huang H; Huang YD; Rao CM; Zhao Y; Liu JS; Wu L; Wei DQ
Peptides; 2006 Apr; 27(4):622-5. PubMed ID: 16242214
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of SSYA10-001 as a replication inhibitor of severe acute respiratory syndrome, mouse hepatitis, and Middle East respiratory syndrome coronaviruses.
Adedeji AO; Singh K; Kassim A; Coleman CM; Elliott R; Weiss SR; Frieman MB; Sarafianos SG
Antimicrob Agents Chemother; 2014 Aug; 58(8):4894-8. PubMed ID: 24841268
[TBL] [Abstract][Full Text] [Related]
35. Identifying inhibitors of the SARS coronavirus proteinase.
Jenwitheesuk E; Samudrala R
Bioorg Med Chem Lett; 2003 Nov; 13(22):3989-92. PubMed ID: 14592491
[TBL] [Abstract][Full Text] [Related]
36. Design and synthesis of peptidomimetic severe acute respiratory syndrome chymotrypsin-like protease inhibitors.
Ghosh AK; Xi K; Ratia K; Santarsiero BD; Fu W; Harcourt BH; Rota PA; Baker SC; Johnson ME; Mesecar AD
J Med Chem; 2005 Nov; 48(22):6767-71. PubMed ID: 16250632
[TBL] [Abstract][Full Text] [Related]
37. Cooperative translocation enhances the unwinding of duplex DNA by SARS coronavirus helicase nsP13.
Lee NR; Kwon HM; Park K; Oh S; Jeong YJ; Kim DE
Nucleic Acids Res; 2010 Nov; 38(21):7626-36. PubMed ID: 20671029
[TBL] [Abstract][Full Text] [Related]
38. Tertiary structure prediction of SARS coronavirus helicase.
Bernini A; Spiga O; Venditti V; Prischi F; Bracci L; Huang J; Tanner JA; Niccolai N
Biochem Biophys Res Commun; 2006 May; 343(4):1101-4. PubMed ID: 16579970
[TBL] [Abstract][Full Text] [Related]
39. Tropolone and its derivatives as inhibitors of the helicase activity of hepatitis C virus nucleotide triphosphatase/helicase.
Borowski P; Lang M; Haag A; Baier A
Antivir Chem Chemother; 2007; 18(2):103-9. PubMed ID: 17542155
[TBL] [Abstract][Full Text] [Related]
40. Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus.
Hoever G; Baltina L; Michaelis M; Kondratenko R; Baltina L; Tolstikov GA; Doerr HW; Cinatl J
J Med Chem; 2005 Feb; 48(4):1256-9. PubMed ID: 15715493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
